Results 41 to 50 of about 11,395,634 (301)

Prevalence of 21 Physician‐Defined Severe Toxicities Following Childhood Acute Lymphoblastic Leukemia Treatment: Australian Retrospective Cohort Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity‐free survival (STFS) framework to determine the prevalence of 21 physician‐defined severe ...
Lane Collier, Brittany Grantham, Camilla Grud Nielsen, Louise Lundgren, Liv Andrés‐Jensen, Kjeld Schmiegelow, Chris Selman, Gareth Ball, Elyse Passmore, David A. Elliott, Rachel Conyers   +10 more
wiley   +1 more source

Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

Nature Biotechnology, 2019
QIIME 2 development was primarily funded by NSF Awards 1565100 to J.G.C. and 1565057 to R.K. Partial support was also provided by the following: grants NIH U54CA143925 (J.G.C. and T.P.) and U54MD012388 (J.G.C. and T.P.); grants from the Alfred P.
Evan Bolyen, J. Rideout, Matthew R. Dillon, N. Bokulich, C. Abnet, Gabriel A. Al-Ghalith, Harriet Alexander, E. Alm, Manimozhiyan Arumugam, F. Asnicar, Yang Bai, J. Bisanz, K. Bittinger, A. Brejnrod, Colin J. Brislawn, C. T. Brown, B. Callahan, A. Caraballo-Rodríguez, John Chase, Emily K. Cope, R. D. da Silva, C. Diener, P. Dorrestein, G. Douglas, D. Durall, C. Duvallet, C. Edwardson, Madeleine Ernst, M. Estaki, Jennifer T. Fouquier, J. Gauglitz, S. Gibbons, D. Gibson, Antonio Gonzalez, Kestrel Gorlick, Jiarong Guo, Benjamin M Hillmann, S. Holmes, H. Holste, C. Huttenhower, G. Huttley, Stefan Janssen, A. Jarmusch, Lingjing Jiang, Benjamin D. Kaehler, K. Kang, Christopher R. Keefe, P. Keim, S. Kelley, D. Knights, I. Koester, T. Kościółek, Jorden Kreps, M. Langille, Joslynn S. Lee, R. Ley, Yong-xin Liu, E. Loftfield, C. Lozupone, Massoud Maher, C. Marotz, Bryan D. Martin, Daniel McDonald, L. McIver, A. Melnik, J. Metcalf, S. C. Morgan, James T. Morton, Ahmad Turan Naimey, Jose A Navas-Molina, Louis-Félix Nothias, Stephanie B. Orchanian, Talima R. Pearson, Samuel L. Peoples, D. Petráš, M. Preuss, Elmar Pruesse, Lasse Buur Rasmussen, A. Rivers, M. Robeson, P. Rosenthal, N. Segata, Michael Shaffer, A. Shiffer, R. Sinha, S. Song, J. Spear, Austin D. Swafford, Luke R. Thompson, P. Torres, Pauline Trinh, A. Tripathi, P. Turnbaugh, Sabah Ul-Hasan, J. V. D. van der Hooft, Fernando Vargas, Y. Vázquez-Baeza, E. Vogtmann, Max von Hippel, William Walters, Yunhu Wan, Mingxun Wang, Jonathan Warren, Kyle C. Weber, C. Williamson, A. Willis, Z. Xu, Jesse R. Zaneveld, Yilong Zhang, Qiyun Zhu, R. Knight, J. Caporaso   +111 more
semanticscholar   +1 more source

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar, Karen Thibaudeau, Mary Mathias, Heather McDaniel, Madlen Reschke, Klaus Tenbrock, Joseph M. Parker, Amy Shapiro   +7 more
wiley   +1 more source

Obsah ročníku /// Volume Contents

Teorie vědy, 2015
Obsah ročníku / Volume ...
Teorie vědy Theory of science
doaj  

Rational Use of Herbal Products in Pediatric Patients Treated With Anticancer Drugs in the European Union

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction The use of herbal medical preparation (HMP) is rising among pediatric oncology patients, often to manage treatment‐related symptoms. Their effectiveness remains uncertain, and the risk of herb–drug interactions is underestimated.
Orianne Mahot, Mathieu Corvaisier, Laurence Spiesser‐Robelet, Mylène Duplan, Isabelle Pellier, Delphine Bourneau‐Martin, Séverine Derbré   +6 more
wiley   +1 more source

Editorial

Teorie vědy, 2012
Editorial.
Teorie vědy Theory of science
doaj  

The science fiction science method

Nature
Predicting the social and behavioral impact of future technologies, before they are achieved, would allow us to guide their development and regulation before these impacts get entrenched. Traditionally, this prediction has relied on qualitative, narrative methods. Here we describe a method which uses experimental methods to simulate future technologies,
Rahwan, Iyad, Shariff, Azim, Bonnefon, Jean-François   +2 more
openaire   +5 more sources

Guidelines for Pediatric Radiotherapy Simulation: A Report From the Children's Oncology Group Radiation Oncology Discipline

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric radiation therapy presents unique challenges compared to adult treatments, including those of immobilization, potential need for sedation, and the critical importance of accurate, reproducible positioning. Additionally, heightened attention to imaging doses is necessary to minimize long‐term toxicity in survivors.
Parham Alaei, Stephen Mihalcik, Sujith Baliga, Young Kwok, Dana Casey, Eric Ehler, Christiane Burton, John C. Breneman, Daphne A. Haas‐Kogan, Suzanne L. Wolden, Arnold C. Paulino, Nadia N. Laack, Natia Esiashvili, Sarah Milgrom, Christine Hill‐Kayser, Thomas J. Fitzgerald, John A. Kalapurakal, Chia‐Ho Hua   +17 more
wiley   +1 more source

The Use of Cronbach’s Alpha When Developing and Reporting Research Instruments in Science Education

Research in Science Education, 2017
Cronbach’s alpha is a statistic commonly quoted by authors to demonstrate that tests and scales that have been constructed or adopted for research projects are fit for purpose. Cronbach’s alpha is regularly adopted in studies in science education: it was
K. Taber
semanticscholar   +1 more source

Improved Early Referral in Long‐Term Survivor Care With Institutional Standardized Practice Among Childhood Leukemia Survivors#

Pediatric Blood &Cancer, EarlyView.
ABSTRACT In 2018, the Texas Children's Cancer and Hematology Center Leukemia Program implemented a practice standard to support the transition from treatment to survivorship that includes shared, alternating care between leukemia and survivorship clinicians and a reminder to refer survivors to the long‐term survivor clinic (LTSC) 2 years after ...
Ji Yun Tark, Kayla L. Foster, Omar Shakeel, Mary C. Shapiro, Shawki L. Qasim, ZoAnn Dreyer, Eric S. Schafer, Ashley M. Butler, Austin L. Brown, Maria Monica Gramatges   +9 more
wiley   +1 more source